OrganiGram (TSXV:OGI) (OTC:OGRMF) is one of 26 names currently on the 420 Investor Focus List. The company, based in Moncton, NB, was one of the early license recipients in Canada's MMPR program and began trading publicly in August, 2014. In the most recent quarter, it grew sales 38% sequentially as it produced positive EBITDA.

I interviewed Denis Arsenault, the CEO of OrganiGram, on April 29th. We covered his background and the background of the company, his outlook for changes ahead in the MMPR program as well as his expectation that Canadians will be able to purchase cannabis legally in late 2017, his company's near-term build-out plans, how the company is differentiated from peers and his views on international expansion. Arsenault suggests that investors focus on the strength of management and the balance sheet and cash flow.

420 Investor has extensive coverage of the Canadian MMPR licensed producers. Additionally, 420 Investor has created an index to track the market and a model portfolio with a goal to exceed the overall market as measured by that index.